8TXE | pdb_00008txe

Crystal structure of KRAS G12D in complex with GDP and compound 5


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.35 Å
  • R-Value Free: 
    0.215 (Depositor), 0.206 (DCC) 
  • R-Value Work: 
    0.188 (Depositor), 0.184 (DCC) 
  • R-Value Observed: 
    0.190 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8TXE

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

Structure-Based Design and Synthesis of Potent and Selective KRAS G12D Inhibitors.

Cheng, H.Li, P.Chen, P.Irimia, A.Bae, J.H.Brooun, A.Fagan, P.Lam, R.Lin, B.Zhang, J.Zhan, X.Wu, X.Xie, N.Chiang, G.Shoemaker, R.Vernier, J.M.

(2023) ACS Med Chem Lett 14: 1351-1357

  • DOI: https://doi.org/10.1021/acsmedchemlett.3c00245
  • Primary Citation Related Structures: 
    8TXE, 8TXG, 8TXH

  • PubMed Abstract: 

    KRAS G12D mutation has been found in approximately 45% of pancreatic ductal adenocarcinoma (PDAC) cases, making it an attractive therapeutic target. Through structure-based drug design, a series of potent and selective KRAS G12D inhibitors were designed. The lead compound, ERAS-5024, inhibited ERK1/2 phosphorylation and cell proliferation in three-dimensional Cell-Titer Glo assays in AsPC-1 PDAC cells with single-digit nanomolar potency and caused tumor regression in the in vivo efficacy studies. We describe here the details of the design and synthesis program that led to the discovery of ERAS-5024.


  • Organizational Affiliation
    • Erasca Inc., 3115 Merryfield Row, Suite 300, San Diego, California 92121, United States.

Macromolecule Content 

  • Total Structure Weight: 40.96 kDa 
  • Atom Count: 3,244 
  • Modeled Residue Count: 340 
  • Deposited Residue Count: 340 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
GTPase KRas
A, B
170Homo sapiensMutation(s): 1 
Gene Names: KRASKRAS2RASK2
EC: 3.6.5.2
UniProt & NIH Common Fund Data Resources
Find proteins for P01116 (Homo sapiens)
Explore P01116 
Go to UniProtKB:  P01116
PHAROS:  P01116
GTEx:  ENSG00000133703 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP01116
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
VM9
(Subject of Investigation/LOI)

Query on VM9



Download:Ideal Coordinates CCD File
E [auth A],
H [auth B]
(6M)-6-(6-chloro-4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-7-yl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine
C29 H31 Cl F5 N7 O
YODMLRHFGATDGU-SBYGXYMLSA-N
GDP

Query on GDP



Download:Ideal Coordinates CCD File
C [auth A],
F [auth B]
GUANOSINE-5'-DIPHOSPHATE
C10 H15 N5 O11 P2
QGWNDRXFNXRZMB-UUOKFMHZSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
D [auth A],
G [auth B]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.35 Å
  • R-Value Free:  0.215 (Depositor), 0.206 (DCC) 
  • R-Value Work:  0.188 (Depositor), 0.184 (DCC) 
  • R-Value Observed: 0.190 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 37.815α = 90
b = 62.166β = 91.86
c = 71.925γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
autoPROCdata reduction
autoPROCdata scaling
BUSTERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other private--

Revision History  (Full details and data files)

  • Version 1.0: 2023-11-08
    Type: Initial release